Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06388746

Arresting Carious Lesions With Minimal Intervention Techniques

Minimal Intervention Techniques for Arresting Caries in Primary Molars: a Randomized Clinical Trial With 12 Months Follow-up.

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
National and Kapodistrian University of Athens · Academic / Other
Sex
All
Age
4 Years – 8 Years
Healthy volunteers
Accepted

Summary

A single-blinded randomized clinical trial with a split-mouth design that will assess the 12-month clinical and radiographic success of two minimally invasive treatment techniques, one using a chemo-mechanical caries removal agent and one using a caries arresting agent, for the treatment of deep caries in primary molars.

Detailed description

Fifty children (100 teeth) aged 4 to 8 years with a non-contributary medical history and at least two carious primary molars (ICDAS 5 and 6) on different quadrants will be randomly assigned to either treatment group, using computer-generated numbers. Each cavitated lesion will be isolated with cotton rolls and air-dried before being treated with one of the two types of minimal intervention technique according to the manufacturer's instructions. After the application of the agents all teeth will be restored using a high viscosity glass ionomer cement. Patients will be followed clinically at 6 and 12 months and radiographically at 12 months to evaluate success of the procedures.

Conditions

Interventions

TypeNameDescription
OTHERBRIX3000®A gel that when applied to the tooth completely removes carious tissues in a chemo mechanical way without rotary instruments. It contains an enzyme that has bactericidal, bacteriostatic and anti-inflammatory properties and proteolytic properties that help soften and break down decayed tissue without destroying the underlying healthy collagen fibers.
OTHERRiva Star Aqua, SDI Limited, AustraliaA solution that contains 44,800 ppm F and 253,870 ppm Ag. It acts as a fluoride storage for the acid challenges, while inhibites demineralization of hydroxyapatite crystals and preserves collagen from degradation in demineralized tissues.

Timeline

Start date
2024-06-01
Primary completion
2025-06-01
Completion
2025-12-01
First posted
2024-04-29
Last updated
2024-04-29

Source: ClinicalTrials.gov record NCT06388746. Inclusion in this directory is not an endorsement.